0000899243-17-014034.txt : 20170522
0000899243-17-014034.hdr.sgml : 20170522
20170522161017
ACCESSION NUMBER: 0000899243-17-014034
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170518
FILED AS OF DATE: 20170522
DATE AS OF CHANGE: 20170522
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ophthotech Corp.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
BUSINESS PHONE: 212-845-8200
MAIL ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROSS MICHAEL JAY
CENTRAL INDEX KEY: 0001254452
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 17860993
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-18
0
0001410939
Ophthotech Corp.
OPHT
0001254452
ROSS MICHAEL JAY
ONE BOSTON PLACE
201 WASHINGTON STREET, SUITE 3900
BOSTON
MA
02108
1
0
0
0
Common Stock
2017-05-18
4
M
0
1750
A
3500
D
Restricted Stock Units
2017-05-18
4
M
0
1750
0.00
D
Common Stock
1750
0
D
Stock Option (right to buy)
2.46
2017-05-19
4
A
0
16000
0.00
A
2017-06-19
2027-05-18
Common Stock
16000
16000
D
Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
As previously reported, on June 2, 2016 the Issuer awarded the Reporting Person a Restricted Stock Unit award which represented the contingent right to receive 1,750 shares of Issuer common stock. Pursuant to the terms of a Restricted Stock Unit Agreement by and between the Reporting Person and the Issuer, this Restricted Stock Unit award vested on May 18, 2017 with respect to 100% of the shares subject to the award, and the shares were issued to the Reporting Person.
Subject to Reporting Person providing continued services to the Issuer and other terms and conditions under a stock option agreement by and between the Reporting Person and the Issuer, The option will vest and become exercisable in 12 consecutive, equal monthly installments commencing on June 19, 2017 until fully vested and exercisable on the first anniversary of the date of grant. Any unvested shares subject to the option will be accelerated in full one business day prior to the Issuer's 2018 annual meeting of stockholders.
/s/ Thomas B. Rosedale (Pursuant to Power of Attorney)
2017-05-22